Do IGF-1 inhibitors really slow down the ageing process?

Researchers have been delving into the hormone IGF-1 and its role in ageing for quite some time. IGF-1 influences the growth and repair of cells in our bodies. Scientists had hoped that slowing down IGF-1 signalling would decelerate the ageing process and thus potentially extend lifespan.

Recent research involving mice with a specific genetic defect in their cells shows that blocking IGF-1 signals does not lead to slower ageing. These mice inherit a mutation that impairs their powerhouses, the mitochondria, and accelerates ageing. The study demonstrates that inhibiting IGF-1 in these animals has no positive effect on their health or lifespan.

This result underscores how complex ageing is and that a single approach is unlikely to be sufficient to stop the process. Even though adjusting IGF-1 signalling can sometimes offer minor benefits, it is not a silver bullet for preventing or reversing the symptoms of ageing. Ageing is an interplay of various biological processes that influence one another.

This is important to know for people who want to age healthily. It means that a healthy lifestyle with good nutrition, exercise and enough relaxation remains the best way for now to combat the symptoms of ageing. Scientists continue to search for new methods, but it is clear that no simple remedy exists for the ageing process.

Source: Reason